ICU Medical, Inc. provided earnings guidance for the Fiscal Year 2024. For the year, the company estimates GAAP net loss to be in the range of $88 million to $71 million and GAAP diluted loss per share estimated to be in the range of $3.57 to $2.87.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
99.68 USD | +0.65% | +4.83% | -0.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.32% | 2.41B | |
-3.84% | 184B | |
-0.75% | 107B | |
-3.02% | 69.44B | |
+3.67% | 50.37B | |
+8.40% | 44.82B | |
+3.40% | 41.53B | |
+3.11% | 26.84B | |
+3.74% | 26.73B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- ICUI Stock
- News ICU Medical, Inc.
- ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2024